https://www.genesispharma.com/newsroom/news/fabryfamilytreegr-a-new-awareness-website-for-people-with-fabry-disease-diagnosis-and-their-families/2024-12-20T09:53:55Zhttps://www.genesispharma.com/newsroom/news/genesis-pharma-enters-into-exclusive-agreement-with-jazz-pharmaceuticals/2024-12-20T09:57:16Zhttps://www.genesispharma.com/newsroom/news/genesis-pharma-enters-into-exclusive-agreement-with-seagen/2024-12-20T09:56:34Zhttps://www.genesispharma.com/newsroom/news-archive/platinum-award-for-genesis-pharma-in-the-greek-corporate-responsibility-index/2024-12-18T14:33:16Zhttps://www.genesispharma.com/newsroom/news/genesis-pharma-announces-expansion-of-commercialization-agreement-with-incyte/2025-11-19T12:06:07Zhttps://www.genesispharma.com/newsroom/news-archive/alnylam-pharmaceuticals-and-genesis-pharma-partner-to-commercialize-patisiran-in-south-east-europe/2024-12-20T10:01:37Zhttps://www.genesispharma.com/newsroom/news-archive/genesis-pharma-announces-a-commercialization-agreement-with-amicus-therapeutics-for-migalastat/2024-12-18T08:44:33Zhttps://www.genesispharma.com/newsroom/news/kyowa-kirin-and-genesis-pharma-announce-new-partnership-for-rare-disease-medicines-portfolio-in-greece-cyprus-and-malta/2025-04-04T13:10:28Zhttps://www.genesispharma.com/newsroom/news/genesis-pharma-announces-an-exclusive-distribution-agreement-with-deciphera-pharmaceuticals-to-commercialize-ripretinib/2025-11-10T09:34:36Zhttps://www.genesispharma.com/newsroom/news/genesis-pharma-announces-an-exclusive-distribution-agreement-with-regeneron-pharmaceuticals/2025-04-04T13:08:07Zhttps://www.genesispharma.com/newsroom/news/genesis-pharma-announces-an-exclusive-distribution-agreement-with-santhera-pharmaceuticals-to-commercialize-vamorolone/2025-04-04T13:07:03Zhttps://www.genesispharma.com/newsroom/news/genesis-pharma-receives-top-diamond-distinction-in-the-greek-corporate-responsibility-index-cr-index/2025-07-03T12:59:37Zhttps://www.genesispharma.com/newsroom/news/genesis-pharma-and-krystal-biotech-agreement-for-genetic-medicine-for-dystrophic-epidermolysis-bullosa/2025-11-10T09:28:27Zhttps://www.genesispharma.com/newsroom/news/genesis-pharma-announces-partnership-with-otsuka-pharmaceutical-europe-ltd-for-donidalorsen/2025-12-15T09:11:30Zhttps://www.genesispharma.com/newsroom/news/daiichi-sankyo-and-genesis-pharma-enter-exclusive-agreement-for-quizartinib-commercialization-in-central-eastern-europe/2026-01-07T08:04:54Z